Clinical Trials Logo

Clinical Trial Summary

A Randomized, Double-Blinded, Aqueous Gel-Controlled Dose Escalating Trial to Study the Safety and Antimicrobial Efficacy of DBI-002 Probiotic vs. Aqueous Gel and Vehicle Gel vs. Aqueous Gel in Adults with Tinea Versicolor (DBI-202).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04937920
Study type Interventional
Source DermBiont, Inc.
Contact
Status Completed
Phase Phase 2
Start date March 16, 2021
Completion date November 4, 2021

See also
  Status Clinical Trial Phase
Completed NCT00830388 - Ketoconazole Foam 2% for the Treatment of Versicolor Phase 4
Completed NCT05862714 - Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor Phase 1
Not yet recruiting NCT05730244 - A Study of the Clinical Efficacy and Safety of 100% Cassia Alata Extract Against Tinea Versicolor Phase 1
Completed NCT04110834 - Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel Phase 2
Completed NCT04110860 - Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel Phase 2
Completed NCT06305637 - A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor. Phase 1